The use of CCR3 antagonists of the formula I or a pharmaceutically acceptable salt thereof for the treatment of asthma is disclosed, as well as novel compounds of the formula II, pharmaceutical compositions comprising them, and their use in the treatment
-
Page/Page column 65
(2008/06/13)
Concise formation of 4-benzyl piperidines and related derivatives using a Suzuki protocol